Literature DB >> 20395619

A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls.

Susan F Stevenson1, Fergus N Doubal, Kirsten Shuler, Joanna M Wardlaw.   

Abstract

BACKGROUND AND
PURPOSE: The etiology of cerebral small vessel disease is unknown. An association with endothelial dysfunction has been suggested. We systematically assessed all relevant studies of dynamic endothelial function in patients with lacunar stroke as a marker of small vessel disease.
METHODS: We searched for studies of cerebral or peripheral vascular reactivity in patients with lacunar or cortical (ie, large artery atheromatous) ischemic stroke or nonstroke control subjects. We calculated standardized mean difference (SMD) in vascular reactivity+/-95% CIs between small vessel disease and control groups.
RESULTS: Sixteen publications (974 patients) were included. In lacunar stroke, cerebrovascular reactivity (n=534) was reduced compared with age-matched normal (SMD -0.94, 95% CI -1.17 to -0.70), but not age+risk factor-matched control subjects (SMD 0.08, 95% CI -0.36 to 0.53) or cortical strokes (SMD -0.29, 95% CI -0.69 to 0.11); forearm flow-mediated dilatation (n=401) was reduced compared with age-matched normal control subjects (SMD -1.04, 95% CI -1.33 to -0.75) and age+risk factor-matched control subjects (SMD -0.94, 95% CI -1.26 to -0.61), but not cortical strokes (SMD -0.23, 95% CI -0.55 to 0.08).
CONCLUSIONS: Endothelial dysfunction is present in patients with lacunar stroke but may simply reflect exposure to vascular risk factors and having a stroke, because a similar degree of dysfunction is found in cortical (large artery atheromatous) stroke. Current data do not confirm that endothelial dysfunction is specific to small vessel stroke. Future studies should include control subjects with nonlacunar stroke.

Entities:  

Mesh:

Year:  2010        PMID: 20395619     DOI: 10.1161/STROKEAHA.109.569855

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  39 in total

1.  Overexpression of HIF-1α protects PC12 cells against OGD/R-evoked injury by reducing miR-134 expression.

Authors:  Hongliang Zhang; Xianming Liu; Fengyu Yang; Dekui Cheng; Wei Liu
Journal:  Cell Cycle       Date:  2020-04-08       Impact factor: 4.534

Review 2.  Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain.

Authors:  Young-Kook Kim; Juhyun Song
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

3.  Comparison of arteriosclerotic indicators in patients with ischemic stroke: ankle-brachial index, brachial-ankle pulse wave velocity and cardio-ankle vascular index.

Authors:  Naoki Saji; Kazumi Kimura; Yoshiki Yagita; Toshitaka Kawarai; Hirotaka Shimizu; Yasushi Kita
Journal:  Hypertens Res       Date:  2015-02-26       Impact factor: 3.872

4.  Endothelial dysfunction is associated with the severity of cerebral small vessel disease.

Authors:  Tomohisa Nezu; Naohisa Hosomi; Shiro Aoki; Satoshi Kubo; Mutsuko Araki; Tomoya Mukai; Tetsuya Takahashi; Hirofumi Maruyama; Yukihito Higashi; Masayasu Matsumoto
Journal:  Hypertens Res       Date:  2015-02-12       Impact factor: 3.872

Review 5.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

Review 6.  The pathobiology of vascular dementia.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2013-11-20       Impact factor: 17.173

Review 7.  Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: A systematic review.

Authors:  Gordon W Blair; Fergus N Doubal; Michael J Thrippleton; Ian Marshall; Joanna M Wardlaw
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-16       Impact factor: 6.200

8.  Genetic variants influencing elevated myeloperoxidase levels increase risk of stroke.

Authors:  Chia-Ling Phuah; Tushar Dave; Rainer Malik; Miriam R Raffeld; Alison M Ayres; Joshua N Goldstein; Anand Viswanathan; Steven M Greenberg; Jeremiasz M Jagiella; Björn M Hansen; Bo Norrving; Jordi Jimenez-Conde; Jaume Roquer; Alexander Pichler; Christian Enzinger; Joan Montaner; Israel Fernandez-Cadenas; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Alessandro Biffi; Natalia Rost; Carl D Langefeld; Hugh S Markus; Braxton D Mitchell; Brad B Worrall; Steven J Kittner; Daniel Woo; Martin Dichgans; Jonathan Rosand; Christopher D Anderson
Journal:  Brain       Date:  2017-10-01       Impact factor: 13.501

9.  Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke.

Authors:  Francesco Arba; Alessio Giannini; Benedetta Piccardi; Silvia Biagini; Vanessa Palumbo; Betti Giusti; Patrizia Nencini; Anna Maria Gori; Mascia Nesi; Giovanni Pracucci; Giorgio Bono; Paolo Bovi; Enrico Fainardi; Domenico Consoli; Antonia Nucera; Francesca Massaro; Giovanni Orlandi; Francesco Perini; Rossana Tassi; Maria Sessa; Danilo Toni; Rosanna Abbate; Domenico Inzitari
Journal:  Eur Stroke J       Date:  2018-10-22

Review 10.  William M. Feinberg Award for Excellence in Clinical Stroke: Small Vessel Disease; a Big Problem, But Fixable.

Authors:  Joanna M Wardlaw
Journal:  Stroke       Date:  2018-06-12       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.